Europe

Taylor joins Bestnet as senior scientist

Monday, October 31, 2011 11:14 AM

Bestnet has named Robert N. Taylor, Ph.D., senior scientist. In addition to a contributory role in the company's product research & development efforts, Taylor's activities will include participation in various scientific/technical working groups and representing Bestnet on scientific committees.

More... »

GSK, University of Edinburgh partner in drug discovery

Wednesday, October 26, 2011 12:53 PM

GlaxoSmithKline (GSK) and the University of Edinburgh have agreed on a collaborative partnership to discover and develop medicines with the potential to treat severe acute pancreatitis.

More... »

CertiVox wins 2011 Bully Award

Tuesday, October 25, 2011 01:43 PM

CertiVox has received the Yearling category of the 2011 Bully Award, an honor presented by White Bull Summits to Europe’s leading technology, media and telecommunications companies.

More... »

APEPTICO successfully completes phase I AP301 trial

Tuesday, October 25, 2011 11:19 AM

APEPTICO has completed a phase I clinical trial for its pulmonary sodium ion channel activator AP301. The orally inhaled drug candidate was safe and well-tolerated by all study participants. AP301 is being developed for the prevention and treatment of oedematous respiratory failure in patients suffering from lung infection, lung injury and lung transplantation.

More... »

Ewopharma acquires Immdal’s Newport Pharmaceuticals

Thursday, October 20, 2011 10:40 AM

Immdal, a privately held Irish pharmaceutical healthcare group, has sold its subsidiary Newport Pharmaceuticals to Swiss pharmaceutical company Ewopharma.

More... »

Almac expands with new facility in UK

Thursday, October 20, 2011 10:11 AM

Almac has expands its pharmaceutical development services with the creation of a new facility at our UK headquarters in Craigavon.

More... »

Genticel completes patient recruitment for ProCervix trial

Wednesday, October 19, 2011 11:31 AM

Genticel has completed the recruitment of all patients participating in its phase one clinical trial with a liquid formulation of ProCervix, its candidate therapeutic HPV vaccine designed for adult women already infected with human papillomavirus (HPV) genotype 16 or 18.

More... »

GENFIT names Larue executive VP, biomarkers

Wednesday, October 19, 2011 10:30 AM

GENFIT, a biopharmaceutical company, has named Dr. Catherine Larue executive vice-president, biomarkers.

More... »

Synexus names Pilgrim chairman

Monday, October 17, 2011 01:01 PM

Alan Pilgrim has taken over as chairman of Synexus from Trevor Jones, who continues on the board as a director and becomes president of the Synexus’ Scientific advisory board.

More... »

ICON names president of DOCS

Monday, October 17, 2011 10:59 AM

ICON has named Colin Stanley president of DOCS, the company’s global resourcing division. Stanley succeeds Mr. Bill Taaffe as president following his retirement earlier this year.

More... »